Press Release
Vadadustat maintains hemoglobin (Hb) levels in dialysis dependent chronic kidney disease (DD-CKD) patients independent of systemic inflammation or prior dose of erythropoiesis stimulating agent (ESA)
Vadadustat maintains hemoglobin (Hb) levels in dialysis dependent chronic kidney disease (DD-CKD) patients independent of systemic inflammation or prior dose of erythropoiesis stimulating agent (ESA)
July 14, 2020 at 1:01 AM EDT
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet
Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142
+1 617.871.2098 phone
+1 617.871.2099 fax